Literature DB >> 12794163

A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system.

Rachel E Kohler1, Adriana C Caon, David O Willenborg, Ian Clark-Lewis, Shaun R McColl.   

Abstract

Chemokines are a family of cytokines that exhibit selective chemoattractant properties for target leukocytes and play a significant role in leukocyte migration. In this study, we have investigated the role of the C-C chemokine, macrophage inflammatory protein (MIP)-3alpha/CC chemokine ligand 20, in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a model of T cell-dependent inflammation. Expression in the CNS of MIP-3alpha, as determined by RT-PCR, increased in a time-dependent manner such that peak expression correlated with peak clinical disease. Similarly, levels of immunoreactive MIP-3alpha in the draining lymph nodes increased up to 10-fold 9 days postimmunization and remained elevated for up to 21 days postimmunization. The increased production of MIP-3alpha coincided with onset of clinical disease. Treatment of mice with specific neutralizing anti-MIP-3alpha Abs significantly reduced the severity of both clinical EAE and neuroinflammation by inhibiting the sensitization of lymphocytes to the specific Ag and release of lymphocytes from the draining lymph nodes. In contrast, adoptive transfer experiments indicated that MIP-3alpha was not essential for the effector phase of EAE. Together, these data demonstrate that MIP-3alpha plays a critical role in the sensitization phase of EAE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794163     DOI: 10.4049/jimmunol.170.12.6298

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.

Authors:  Lena Schiffer; Ramalingam Bethunaickan; Meera Ramanujam; Weiqing Huang; Mario Schiffer; Haiou Tao; Michael P Madaio; Michael M Madaio; Erwin P Bottinger; Anne Davidson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 2.  Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation.

Authors:  Zsuzsanna Fabry; Heidi A Schreiber; Melissa G Harris; Matyas Sandor
Journal:  Curr Opin Pharmacol       Date:  2008-09-02       Impact factor: 5.547

3.  C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

Authors:  Andrea Reboldi; Caroline Coisne; Dirk Baumjohann; Federica Benvenuto; Denise Bottinelli; Sergio Lira; Antonio Uccelli; Antonio Lanzavecchia; Britta Engelhardt; Federica Sallusto
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

4.  A chemokine-like viral protein enhances alpha interferon production by plasmacytoid dendritic cells but delays CD8+ T cell activation and impairs viral clearance.

Authors:  Matthew E Wikstrom; Peter Fleming; Iain Comerford; Shaun R McColl; Christopher E Andoniou; Mariapia A Degli-Esposti
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.

Authors:  Chang-hong Li; Lin-lin Xu; Jin-xia Zhao; Lin Sun; Zhong-qiang Yao; Xiao-li Deng; Rui Liu; Lin Yang; Rui Xing; Xiang-yuan Liu
Journal:  Inflamm Res       Date:  2015-11-30       Impact factor: 4.575

6.  Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites.

Authors:  Ervin E Kara; Iain Comerford; Cameron R Bastow; Kevin A Fenix; Wendel Litchfield; Tracy M Handel; Shaun R McColl
Journal:  J Immunol       Date:  2013-06-24       Impact factor: 5.422

7.  CXCL16 regulates cell-mediated immunity to Salmonella enterica serovar Enteritidis via promotion of gamma interferon production.

Authors:  Olivier L Fahy; Scott L Townley; Shaun R McColl
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 8.  Type17 T-cells in central nervous system autoimmunity and tumors.

Authors:  Hideho Okada; Samia J Khoury
Journal:  J Clin Immunol       Date:  2012-03-28       Impact factor: 8.317

9.  Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis.

Authors:  Adam Elhofy; R William Depaolo; Sergio A Lira; Nicholas W Lukacs; William J Karpus
Journal:  J Neuroimmunol       Date:  2009-06-17       Impact factor: 3.478

10.  Macrophage Inflammatory Protein-3 Alpha (MIP-3α)/CCL20 in HIV-1-Infected Individuals.

Authors:  Najib Aziz; Roger Detels; L Cindy Chang; Anthony W Butch
Journal:  J AIDS Clin Res       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.